share_log

Earnings Call Summary | CNO Financial Group Inc(CNO.US) Q1 2024 Earnings Conference

Earnings Call Summary | CNO Financial Group Inc(CNO.US) Q1 2024 Earnings Conference

業績電話會議摘要 | 中諾金融集團公司(CNO.US)2024 年第一季度業績發佈會
富途資訊 ·  05/01 09:48  · 電話會議

The following is a summary of the CNO Financial Group, Inc. (CNO) Q1 2024 Earnings Call Transcript:

以下是CNO金融集團有限公司(CNO)2024年第一季度業績電話會議記錄的摘要:

Financial Performance:

財務業績:

  • CNO reported strong Q1 results with an increase in total new annualized premium by 8%.

  • The company posted operating earnings per share of $0.52, due to favorable insurance product margins and portfolio book yield expansion.

  • There was a setback of $24.3 million in unfavorable mark-to-market pre-tax impacts on alternative investments in real estate.

  • However, total net investment income rose and reported a strong capital and liquidity status, returning $57 million to shareholders.

  • The diluted share's book value, excluding AOCI, was up by 10% to $34.97.

  • CNO公佈了強勁的第一季度業績,新年化保費總額增長了8%。

  • 該公司公佈的每股營業收益爲0.52美元,這要歸因於良好的保險產品利潤率和投資組合賬面收益率的擴大。

  • 房地產另類投資因按市值計價的不利稅前影響受到了2430萬美元的挫折。

  • 但是,總淨投資收入增長並報告了強勁的資本和流動性狀況,爲股東帶來了5700萬美元的回報。

  • 攤薄後的股票賬面價值(不包括AOCI)上漲了10%,至34.97美元。

Business Progress:

業務進展:

  • The launch of an expanded growth scorecard focused on production, distribution, and capital investments.

  • Significant sales growth among both consumers and worksite settings.

  • There was a growth in annuity collected premiums by 6% and a 32% increase in brokerage and advisory client assets.

  • Initiatives have been introduced to increase worksite sales and client acquisition.

  • The company reaffirmed annual guidance, expecting it to be driven by a diverse product portfolio and improved alternative investment performance.

  • CNO has seen strong growth in its Medicare Advantage/Medicare Supplement segment and has undertaken efforts to manage distribution risk effectively.

  • The company is open to acquisitions, given careful consideration of valuations.

  • 推出以生產、分銷和資本投資爲重點的擴展型增長記分卡。

  • 消費者和工作場所的銷售額均大幅增長。

  • 年金收取的保費增長了6%,經紀和諮詢客戶資產增長了32%。

  • 已經出臺了一些舉措,以增加工作場所的銷售和客戶的獲取。

  • 該公司重申了年度指引,預計其將受到多元化產品組合和另類投資業績改善的推動。

  • CNO的Medicare Advantage/Medicare補充劑板塊實現了強勁增長,並已努力有效管理分銷風險。

  • 考慮到估值,該公司對收購持開放態度。

更多詳情: CNO 金融集團公司 IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論